Group One Trading, L.P. Altamira Therapeutics Ltd. Transaction History

Group One Trading, L.P.

  • $2.4 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 09, 2022
SELL
$0.27 - $120.04 $4,273 - $1.9 Million
-15,829 Reduced 19.64%
64,776 $19,000
Q2 2022

Aug 11, 2022
BUY
$0.48 - $1.66 $13,374 - $46,252
27,863 Added 52.83%
80,605 $39,000
Q1 2022

May 12, 2022
BUY
$0.69 - $1.92 $793 - $2,208
1,150 Added 2.23%
52,742 $58,000
Q4 2021

Feb 11, 2022
BUY
$1.28 - $2.4 $64,042 - $120,079
50,033 Added 3209.3%
51,592 $94,000
Q3 2021

Nov 12, 2021
BUY
$2.01 - $3.58 $3,133 - $5,581
1,559 New
1,559 $3,000

About Altamira Therapeutics Ltd.

CYTO Quotes by TradingView
  • Ticker CYTO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,009,710
  • Market Cap $172K
  • Description
  • Altamira Therapeutics Ltd. engages in developing therapeutics that address various unmet medical needs. Its commercial products include Bentrio, a drug-free nasal spray for personal protection against airborne viruses and allergens. The company is also involved in the development of RNA therapeutics for extrahepatic therapeutic targets, includin...
More about CYTO
Track This Portfolio

Track Group One Trading, L.P. Portfolio

Follow Group One Trading, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email